Leuthold Group’s Pediatrix Medical MD Stock Holding History

Leuthold Group’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-89,914	Closed	-$3.89M	–	205
2018 Q2	$3.89M	Buy	89,914 +369	+0.4%	+$17.7K	0.43%	86
2018 Q1	$4.98M	Buy	+89,545	New	+$4.91M	0.57%	63
2014 Q2	–	Sell	-31,921	Closed	-$1.98M	–	213
2014 Q1	$1.98M	Buy	31,921 +11,429	+56%	+$665K	0.18%	145
2013 Q4	$1.09M	Buy	+20,492	New	+$1.1M	0.1%	175

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Leuthold Group's MD Position: Q3 2018 in Review

Leuthold Group sold out of Pediatrix Medical (MD) in Q3 2018, closing a stake of 89,914 shares — an estimated $3.89M sold.

Leuthold Group first reported a position in MD in Q4 2013 and held it in 4 quarters. The position peaked at $4.98M in Q1 2018. 320 funds tracked by Wall St. Rank hold MD as of Q3 2018.

Leuthold Group reported no remaining Pediatrix Medical position as of Q3 2018 after selling out during the quarter.
Leuthold Group sold 89,914 Pediatrix Medical shares in Q3 2018, an estimated $3.89M.
Leuthold Group first reported a position in Pediatrix Medical in Q4 2013 and held it in 4 quarters.
Leuthold Group's Pediatrix Medical position peaked at $4.98M in Q1 2018.
320 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2018.

Based on Leuthold Group's 13F filing for Q3 2018, filed 14 Nov 2018.